Jiangsu Hengrui Medicine Co., Ltd.

This study tests an experimental cream called SHR0302Base in 155 adults with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the cream can safely restore color, especially on the face and neck, compared to a cream without the active…

This study tests whether a combination of two drugs (camrelizumab and famitinib) works better than standard chemotherapy for people with cervical cancer that has returned or spread. About 443 participants will be randomly assigned to one of the two treatments. The goal is to see …

This study tests a new drug called SHR-A1811, given alone or with another drug (pertuzumab), against the current standard treatment for HER2-positive breast cancer that has come back or spread. About 868 women aged 18 to 75 with this type of cancer will take part. The goal is to …